About us

At a glance

To meet a broad range of skin health needs, we offer a range of leading medical and consumer skin health brands, through three business units: Prescription, Aesthetics (both under the Galderma brand), and Consumer care.

Key facts

7 innovation areas

We focus our innovation on 7 areas: acne, rosacea, psoriasis, atopic dermatitis, skin ageing, sun protection and skin cancer.

6 manufacturing sites

In 2017, the 1,200+ employees at our 6 manufacturing sites produced 215 million units. We make 75% of our products in-house.

World presence

We operate from 50 sites in 40 countries, with our headquarters in Lausanne, Switzerland.

Sales by region

North America 49%
International 51%

Sales by business

Consumer 43%
Aesthetics 32%
Prescription 25%

Creating shared value

We collaborate with the broad skin health community:

  • Industry-leading medical education with Derm101

  • Promoting community initiatives in dermatology

  • Engaging with the dermatology community

       CSR Policy Financial Year 2017-2018

       CSR Policy Financial Year 2018-2019

       CSR Policy Financial Year 2019-2020


A timeline of our history

Foundation of Galderma

Galderma discovers Adapalene

Opening of production site in Hortolândia, Brazil

Launch of Differin 0.3%

Launch of Epiduo

Launch of Azzalure and Restylane Injector



Acquisition of Q-med, maker of Restylane

Nestlé Skin Health is founded

Galderma debuts as the world's largest independent global dermatology company